| Literature DB >> 35557822 |
A K M Atique Ullah1,2, M F Kabir3, M Akter4, A N Tamanna3, A Hossain5, A R M Tareq1,2, M N I Khan1,6, A K M Fazle Kibria1,7, Masaaki Kurasaki4, M M Rahman3.
Abstract
Persuaded by the necessity of finding new sources of antibiotics, silver nanoparticles (Ag NPs) were synthesized by adopting a newly developed green synthesis technique and subsequently, their antibacterial activity against different pathogenic bacteria was evaluated. We have successfully synthesized bio-molecule capped ferromagnetic Ag NPs with an average crystallite size of 13 nm using AgNO3 solution as a precursor and Artocarpus heterophyllus leaf extract as a reducing and capping agent. The characterization of the synthesized Ag NPs was carried out using various techniques such as UV-visible (UV-Vis) spectroscopy, energy dispersive X-ray (EDX) spectroscopy, Fourier transform infrared (FT-IR) spectroscopy, field emission scanning electron microscopy (FESEM), transmission electron microscopy (TEM), thermogravimetry (TG), and vibrating sample magnetometer (VSM) analyses. After exposing the synthesized Ag NPs to two Gram-positive bacteria - Staphylococcus aureus and Bacillus cereus and two Gram-negative bacteria - Escherichia coli and Salmonella typhimurium, the zones of inhibition were found to be 15, 16, 19, and 18 mm, respectively. These results imply that the Artocarpus heterophyllus leaf extract mediated green synthesized bio-molecules encapsulated Ag NPs can be considered as a potential antibiotic against human pathogens which is very encouraging. This journal is © The Royal Society of Chemistry.Entities:
Year: 2018 PMID: 35557822 PMCID: PMC9088908 DOI: 10.1039/c8ra06908e
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 1Schematic diagram of the synthesis of Ag NPs.
Fig. 2(a) UV-Vis spectrum of Ag NPs produced by the reduction of AgNO3 solution (1 mM) with Artocarpus heterophyllus leaf extract; inset shows the colors of: (i) the aqueous solution of AgNO3, (ii) Artocarpus heterophyllus leaf extract, and (iii) the colloidal solution, respectively. (b) EDX image showing the presence of Ag NPs and bio-organic components of Artocarpus heterophyllus leaf extract.
Fig. 3(a) FT-IR spectra of Artocarpus heterophyllus (AH) leaf powder and AH leaf extract mediated synthesized Ag NPs. (b) TGA plot for as-synthesized Ag NPs synthesized using Artocarpus heterophyllus leaf extract and AgNO3 solution.
Fig. 4(a) FESEM image showing the surface morphology of Ag NPs synthesized using Artocarpus heterophyllus (AH) leaf extract and AgNO3 solution. (b) TEM image showing the particle size of encapsulated Ag NPs synthesized using AH leaf extract and AgNO3 solution.
Fig. 5The Rietveld refinement of the XRD pattern of Ag NPs synthesized using Artocarpus heterophyllus leaf extract and AgNO3 solution. The inset shows the cubic structure of Ag NPs.
Fig. 6The magnetization curve of Ag NPs synthesized using Artocarpus heterophyllus leaf extract and AgNO3 solution. The inset shows the enlargement view of the hysteresis loop.
Fig. 7Antibacterial activity of (1) deionized water, (2) leaf extract and (3) Ag NPs against Gram positive (a) Staphylococcus aureus and (b) Bacillus cereus, and Gram negative (c) Escherichia coli and (d) Salmonella typhimurium pathogenic bacteria.
Various biosynthesized Ag NPs induced zones of inhibition against pathogenic bacteria
| Pathogenic bacteria | Extracted substances | Size of Ag NPs (nm) | Concentration of Ag NPs (mg L−1) | Zones of inhibition (mm) | Reference |
|---|---|---|---|---|---|
|
|
| 19–30 | 100 | 14.7 |
|
|
| 12–15 | 100 | 6 |
| |
|
| 20–50 | 100 | 4.5 |
| |
|
| 20–80 | 100 | 10.8 |
| |
|
| 10–30 | 50 | 18.1 |
| |
|
| 15–40 | 17.7 | |||
|
| 25–60 | 16.5 | |||
|
|
|
|
|
| |
|
| Phlomis | 19–30 | 100 | 15.1 |
|
|
| 16–95 | 100 | 4 |
| |
|
| 12 | 100 | 5 |
| |
|
| 10–20 | 150 | 14 |
| |
|
| 19.75 | 100 | 2.5 |
| |
|
| 20–80 | 100 | 10.8 |
| |
|
|
|
|
|
| |
|
|
| 19–30 | 100 | 14.9 |
|
|
| 16–95 | 100 | 9 |
| |
|
| 20–80 | 100 | 10.4 |
| |
|
| 10–30 | 50 | 6.3 |
| |
|
| 15–40 | 5.5 | |||
|
| 25–60 | 6.0 | |||
|
|
|
|
|
| |
|
|
| 19–30 | 100 | 12.1 |
|
|
| 20–80 | 100 | 10.8 |
| |
|
| 10–30 | 50 | 11.4 |
| |
|
| 15–40 | 9.4 | |||
|
| 25–60 | 12.7 | |||
|
|
|
|
|
|